<DOC>
	<DOCNO>NCT02439307</DOCNO>
	<brief_summary>A total 46 patient diagnose liver cirrhosis recruit . All patient evaluate five psychometric test critical flicker frequency diagnosis minimal hepatic encephalopathy ( MHE ) . A breath test sample perform patient MHE 10 g lactulose establish diagnosis small intestinal bacterial overgrowth ( SIBO ) . Patients diagnose EHM SIBO randomize receive per day 1200 mg rifaximin ( group A ) placebo ( group B ) 2 week . A complete medical history , nutritional assessment , biochemical study , evaluation quality life perform patient include study . Besides initial visit , patient receive subsequent care 2 , 4 , 8 , 12 , 24 week begin study .</brief_summary>
	<brief_title>Effect Rifaximin Minimal Hepatic Encephalopathy Small Intestinal Bacterial Overgrowth</brief_title>
	<detailed_description>MHE impair quality life , increase risk motor vehicle accident , mortality . Currently , consensus treatment yet prove treatment option . Among factor associate MHE , small intestinal bacterial overgrowth ( SIBO ) present 38.6 % patient MHE . Rifaximin broad spectrum antimicrobial administer orally , low risk induce bacterial resistance , use treatment MHE . It unknown beneficial effect MHE associate elimination SIBO efficacy administer patient simultaneous diagnosis MHE SIBO never evaluate . The aim study evaluate effect rifaximin MHE SIBO patient cirrhosis .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Diagnosis cirrhosis etiology Men woman 18 70 year . Patients diagnose minimal hepatic encephalopathy small intestinal bacterial overgrowth Rightholders Mexican Social Security Institute Patients agree participate study sign informed consent Recent history alcohol abuse and/or drug ( less 6 week ) . Illiterate Alcoholic cirrhosis History and/or diagnosis overt hepatic encephalopathy Consumption psychotropic medication ( benzodiazepine , antiepileptic ) Patients treatment lactulose , lacitol , rifaximin , neomycin , metronidazole and/or fiber supplement . History chronic renal disease heart failure Patients gastrointestinal bleed History neurological psychiatric disorder affect ability develop neuropsychological test Patients diarrhea Diagnosis liver cancer Patients ophthalmologic disorder Patients take antibiotic 30 day study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Rifaximin</keyword>
	<keyword>Minimal hepatic encephalopathy</keyword>
</DOC>